PeptideStack
5.2kquestions
20kanswers
220users

What should I make of a dulaglutide documentation package that has no sampling plan?

Asked 3 Mar 2025Modified 13 months agoViewed 12k times
19

Setup, so nobody has to ask: dulaglutide · sampling plan.

I have read the primary source rather than the summary, which has left me with more questions.

I understand the headline. I do not understand the footnotes, and the footnotes look important.

How should I read this, and where are the traps?

coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

771 questions
vendor-vetting
vendor-vetting

Evaluating a supplier on evidence rather than reputation: testing history across batches, whether certificates are batch-specific, how failures…

454 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

910 questions
dulaglutide
dulaglutide

A once-weekly GLP-1 receptor agonist built on an Fc fusion rather than fatty-acid acylation. Use this tag for questions about the fusion-protein…

200 questions
shareeditfollowflag
TW
askedtamsin_wray9.9k163 Mar 2025

5 Answers

Accepted answer first, then by votes
120

Accepted answer

Start from what the certificate claims to measure and what the claimed measurement actually answers, because those are two different questions.

The laboratory name and accreditation status can be checked in real time against the testing service's own register, and that two-minute check catches substituted certificates.

Mass shifts and what they usually mean

Δ mass (Da)Most likely causeDistinguishing feature
+1Deamidation (Asn or Gln)New peak, slightly earlier retention
−17Loss of ammoniaOften with deamidation
−18Dehydration / succinimidepH-dependent, reversible
+16Oxidation (Met, Trp)Earlier retention, light-related
−128Missing Gln or LysDeletion sequence from synthesis
0Isomer: racemisation or scramblingSame mass, shifted retention

A purity figure to two decimal places with no supporting chromatogram is giving false precision and is a red flag on the same level as spelling errors.

Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.

If the certificate does not trace to your vial, it is not evidence about your vial.

shareimprove this answerflag
EL
answered · acceptedesben_lykke84k15821 Jun 2025
8Thank you — this is the answer I was looking for. – Dr_Otto_Lindqvist 29 days ago
7The system-suitability data is the part that tells you whether to believe the rest. – kelvin_lam 9 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
47

Before anything else, check that the lot number on the certificate matches the vial in your hand — that traces back to your material and not to some other lot from some other date.

Batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.

In practice, the certificate is a snapshot and nothing else — it tells you about the material on one day from one sample of one lot, and extrapolation beyond that requires logic.

The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.

The limitation is cost — truly rigorous testing on every lot is expensive enough that most people do not do it, which is exactly why the variation matters.

My working rule is that a document without a lot number, a method section and a test date is marketing.

shareimprove this answerflag
RC
answeredRP_C18105k3484 Mar 2025
7Two of us submitted the same lot to different laboratories and got results a tenth apart. – oona_kekkonen 2 months ago
add a comment
37

A useful certificate has five elements: the lot number, the analytical method, the reported result with units, the date of analysis, and the primary data or a reference to it.

Multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.

Specifically, comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.

Be careful not to over-read this — a certificate that is imperfect is not worthless, it is just a starting point for thought rather than an endpoint.

The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.

edited 4 Apr 2025 by wren_calloway — added the method parameters

shareimprove this answerflag
WC
answeredwren_calloway23k3816 Mar 2025
7Confirming from the other direction: I ignored the method section once and paid for it. – sian_llewellyn 2 months ago
6I would gently push back on the second point — inter-laboratory spread is wider than stated. – assay_blank 19 days ago
add a comment
30

The certificate is not the answer to your question; it is a data point that you need to combine with other information to build an answer.

Test results from a material supplier are different from independent results in ways that matter for interpretation, even if both are accurate.

Pharmacopoeial standards require method validation steps that research-grade certificates almost never claim to meet, and the absence of that claim is itself information.

If you only pay for one test, pay for quantified content. Purity is the number everyone quotes and content is the number that changes what you do.

shareimprove this answerflag
NN
answerednine_point_nine60k14827 Mar 2025
26

The certificate is only as useful as the lot number, because without traceability it is gossip about someone else's material.

The test date matters because a certificate six months older than the vial is not evidence about your material, it is evidence about what the material was like half a year ago.

Industry guidance on this topic is consistent because it comes from first principles rather than convention.

In practice: ask for the chromatogram, check the method section, check the lot number against the vial, and set your accept threshold before you see the result rather than after.

shareimprove this answerflag
EL
answeredesben_lykke84k1588 May 2025
6The distinction between purity and content cannot be repeated often enough here. – rukhsana_iqbal 3 months ago
5Same experience here, different supplier. – Dr_Priya_Raghunathan 2 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.